Fine Biotics

Ahmedabad, India
Manufactures high-quality pharmaceutical products including Beta-Lactam dry powder injections.

About Fine Biotics

Fine Biotics is a Healthcare company based in Ahmedabad (India). It manufactures high-quality pharmaceutical products including Beta-Lactam dry powder injections. It operates on a B2B model. The company has 53 employees. Its Indian entity Finebiotics Pharma Limited reported revenue of β‚Ή26.36 Cr. Fine Biotics offers products and services including Beta-Lactam Dry Powder Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing and Injections. Its competitors include Gland Pharma and Nitin Lifesciences.

Company details

Finebiotics Pharma Ltd. operates state-of-the-art manufacturing facilities for Beta-Lactam dry powder injections, emphasizing quality and excellence in pharmaceutical production. The company merges experienced teams and resources to provide ethical, high-standard pharma products. Based in Gujarat, India, it focuses on innovative drug manufacturing and corporate governance to meet industry needs.

Key Metrics
  • Annual Revenue
    ₹26.36 Cr

    FY 2025 · -21% YoY

  • Net Loss
    -₹2.27 Cr

    FY 2025 · -9% margin

  • EBITDA
    -₹1.56 Cr

    FY 2025 · -6% margin

  • Employee Count
    53

Products & Services of Fine Biotics

Fine Biotics offers a comprehensive portfolio of products and services, including Beta-Lactam Dry Powder Injections.

Beta-Lactam Dry Powder Injections
Pharmaceutical Products

Produces injections for treating bacterial infections in medical settings.

Board of directors of Finebiotics Pharma Limited (Fine Biotics)

Finebiotics Pharma Limited is the primary company behind Fine Biotics. The board of Finebiotics Pharma Limited currently have 7 directors; the longest-serving is Vivek Rajgarhia, appointed in 2012. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vivek Rajgarhia
DIN 00225406
Director16 Aug 201214 yrs 2 moFinebiotics Pharma Limited
Vedprakash Amarchand Agarwal
DIN 03504243
Whole-time director16 Aug 201214 yrs 2 moFinebiotics Pharma Limited
Pradipbhai Ratilal Shah
DIN 06381840
Director16 Aug 201214 yrs 2 moFinebiotics Pharma Limited
Mukesh Tarachand Agarwal
DIN 00118813
Director14 Jun 20179 yrs 4 moFinebiotics Pharma Limited
Mayank Rajeev Kedia
DIN 08772355
Director01 Jul 20206 yrs 3 moFinebiotics Pharma Limited
Parshva Shashikant Jhaveri
DIN 02869621
Director17 Dec 20205 yrs 10 moFinebiotics Pharma Limited
Niraj Kumar Harodia
DIN 06676837
Director28 Jan 20251 yr 8 moFinebiotics Pharma Limited

Financials of Fine Biotics

Figures of Finebiotics Pharma Limited, the primary company behind Fine Biotics, for FY 2025. Revenue was ₹26.36 Cr (-21% year on year). Net loss was -₹2.27 Cr (-9% margin). EBITDA was -₹1.56 Cr (-6% margin). Revenue has grown at a compounded annual rate of -6% over three years and +2% over five years.

  • ₹26.36 CrRevenue · FY 2025 · -21% YoY
  • -₹2.27 CrNet loss · -9% margin
  • -₹1.56 CrEBITDA · -6% margin
  • ₹11.50 CrPaid-up capital
  • 53Employees (provident fund records)
  • -6%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Finebiotics Pharma Limited are on its company page.

Premium access

Detailed financial statements for Fine Biotics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Fine Biotics

Fine Biotics has 2 listed competitors in our database. They include Gland Pharma and Nitin Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
glandpharma.com1978Hyderabad, India4,319
Generic injectable drugs are manufactured across therapeutic segments.
nitinlifesciences.com1994Karnal, India56
CMO of small volume parenteral injectables
Premium access

Detailed competitors of Fine Biotics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fine Biotics

Fine Biotics is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Fine Biotics has 53 employees.

The primary company behind Fine Biotics, Finebiotics Pharma Limited, reported revenue of β‚Ή26.36 Cr for FY 2025, down 21% year on year.

Finebiotics Pharma Ltd. operates state-of-the-art manufacturing facilities for Beta-Lactam dry powder injections, emphasizing quality and excellence in pharmaceutical production. The company merges experienced teams and resources to provide ethical, high-standard pharma products. Based in Gujarat, India, it focuses on innovative drug manufacturing and corporate governance to meet industry needs.

Fine Biotics's top competitors include Gland Pharma and Nitin Lifesciences.

Fine Biotics offers Beta-Lactam Dry Powder Injections.

Fine Biotics operates through Finebiotics Pharma Limited.

The legal entities of Fine Biotics currently have 9 directors, including Vivek Rajgarhia, Niraj Kumar Harodia, Mayank Rajeev Kedia and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available